Picture of Replek AD Skopje logo

REPL Replek AD Skopje Share Price

0.000.00%
mk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m+0.97%
3m+3.4%
6m-86.4%
1yr-84.5%
Volume Change (%)
10d/3m-57.61%
Price vs... (%)
52w High-88%
50d MA+0.87%
200d MA-76.92%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital14.25%
Return on Equity16.26%
Operating Margin18.41%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueMKDm1,049.031,251.271,220.161,251.671,587.37n/an/a10.24%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+34.36+23.52-19.46-23.12+429.26n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Replek AD Skopje EPS forecast chart

Profile Summary

Replek AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the production of generic medicines in different pharmaceutical therapeutic categories, such as oral dosage forms: tablets, capsules and oral solution, as well as medicines for topical use: creams and ointments. The Company has two wholly owned subsidiaries: Replek Farm DOOEL Skopje, a company for manufacturing pharmaceuticals and chemical products and PZU Apteka Replek, a company for import-export, wholesale and retail trade of pharmaceuticals, medical devices and medical equipment; as well as Replek i Hubo International DOO Skopje, a mixed ownership - 80% owned by Replek AD Skopje and 20% owned by Hubo International - Belgium, which comprises the market Replek and Hubo and the restaurant Day and Night.

Directors

Last Annual
December 31st, 2023
Last Interim
September 30th, 2024
Incorporated
February 5th, 1999
Public Since
January 21st, 2003
No. of Employees
426
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
mk flag iconMacedonian Stock Exchange
Shares in Issue
23,809

REPL Share Price Performance

Upcoming Events for REPL

Replek AD Skopje Annual Shareholders Meeting

Similar to REPL

Picture of Alkaloid AD Skopje logo

Alkaloid AD Skopje

mk flag iconMacedonian Stock Exchange

FAQ